ID   BPH-1-CAFTD-04
AC   CVCL_4756
SY   BPH1-CAFTD-04; BPH1CAFTD-4; BPH1CAFTD-04; BPH1(CAFTD)4; BPH1(CAFTD)-04
DR   SKY/M-FISH/CGH; 1514
DR   Wikidata; Q54798087
RX   PubMed=11719442;
RX   PubMed=11719443;
RX   PubMed=15643173;
WW   https://web.archive.org/web/20150602153556/http://capcelllines.ca:80/details.asp?id=133
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C2897; Benign prostatic hyperplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4755 ! BPH-1-CAFTD-03
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=11719442;
RA   Hayward S.W., Wang Y.-Z., Cao M., Hom Y.K., Zhang B.-H., Grossfeld G.D.,
RA   Sudilovsky D., Cunha G.R.;
RT   "Malignant transformation in a nontumorigenic human prostatic
RT   epithelial cell line.";
RL   Cancer Res. 61:8135-8142(2001).
//
RX   PubMed=11719443;
RA   Phillips J.L., Hayward S.W., Wang Y.-Z., Vasselli J., Pavlovich C.P.,
RA   Padilla-Nash H.M., Pezullo J.R., Ghadimi B.M., Grossfeld G.D.,
RA   Rivera A., Linehan W.M., Cunha G.R., Ried T.;
RT   "The consequences of chromosomal aneuploidy on gene expression
RT   profiles in a cell line model for prostate carcinogenesis.";
RL   Cancer Res. 61:8143-8149(2001).
//
RX   PubMed=15643173; DOI=10.1097/01.ju.0000149989.01263.dc;
RA   Sobel R.E., Sadar M.D.;
RT   "Cell lines used in prostate cancer research: a compendium of old and
RT   new lines -- part 2.";
RL   J. Urol. 173:360-372(2005).
//